rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
23
|
pubmed:dateCreated |
1996-12-6
|
pubmed:abstractText |
Allelic loss of chromosome 18q predicts a poor outcome in patients with stage II colorectal cancer. Although the specific gene inactivated by this allelic loss has not been elucidated, the DCC (deleted in colorectal cancer) gene is a candidate. We investigated whether the expression of the DCC protein in tumor cells is a prognostic marker in colorectal carcinoma.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0028-4793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
335
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1727-32
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8929264-Aged,
pubmed-meshheading:8929264-Cell Adhesion Molecules,
pubmed-meshheading:8929264-Colorectal Neoplasms,
pubmed-meshheading:8929264-Female,
pubmed-meshheading:8929264-Gene Expression,
pubmed-meshheading:8929264-Genes, DCC,
pubmed-meshheading:8929264-Humans,
pubmed-meshheading:8929264-Immunohistochemistry,
pubmed-meshheading:8929264-Life Tables,
pubmed-meshheading:8929264-Male,
pubmed-meshheading:8929264-Middle Aged,
pubmed-meshheading:8929264-Neoplasm Staging,
pubmed-meshheading:8929264-Prognosis,
pubmed-meshheading:8929264-Proportional Hazards Models,
pubmed-meshheading:8929264-Receptors, Cell Surface,
pubmed-meshheading:8929264-Survival Rate,
pubmed-meshheading:8929264-Tumor Markers, Biological,
pubmed-meshheading:8929264-Tumor Suppressor Proteins
|
pubmed:year |
1996
|
pubmed:articleTitle |
The DCC protein and prognosis in colorectal cancer.
|
pubmed:affiliation |
Department of Surgery, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|